Skip to Main Content

Key Clinical Updates in Rheumatoid Arthritis

Because rituximab reduces the humoral immune response, it should be used with caution during the COVID-19 pandemic as multiple studies suggest a higher risk of mortality from COVID-19 in patients using this medication.

Fraenkel L et al. Arthritis Care Res (Hoboken). [PMID: 34101387]

ESSENTIALS OF DIAGNOSIS

  • Usually insidious onset with morning stiffness and joint pain.

  • Symmetric polyarthritis with predilection for small joints of the hands and feet; deformities common with progressive disease.

  • Radiographic findings: juxta-articular osteoporosis, joint erosions, and joint space narrowing.

  • Rheumatoid factor and antibodies to cyclic citrullinated peptides (anti-CCP) are present in 70–80%.

  • Extra-articular disease: subcutaneous nodules, interstitial lung disease, pleural effusion, pericarditis, splenomegaly, scleritis, and vasculitis.

GENERAL CONSIDERATIONS

Rheumatoid arthritis is a chronic systemic inflammatory disease whose major manifestation is synovitis of multiple joints. It has a prevalence of 1% and is more common in women than men (female:male ratio of 3:1). Rheumatoid arthritis can begin at any age, but the peak onset is in the fourth or fifth decade for women and the sixth to eighth decades for men. The cause is not known. Susceptibility to rheumatoid arthritis is genetically determined with multiple genes contributing. Inheritance of HLA-DRB1 alleles encoding a distinctive five-amino-acid sequence known as the “shared epitope” is the best characterized genetic risk factor. Untreated, rheumatoid arthritis causes joint destruction with consequent disability and shortens life expectancy. Early, aggressive treatment is the standard of care.

The pathologic findings in the joint include chronic synovitis with formation of a pannus, which erodes cartilage, bone, ligaments, and tendons (eFigure 20–14). Effusion and other manifestations of inflammation are common. In the late stage, organization may cause fibrous ankylosis; true bony ankylosis is rare.

eFigure 20–14.

Synovitis bilaterally at multiple metacarpal phalangeal joints in a patient with rheumatoid arthritis. (Used, with permission, from Nicole Richman, MD.)

CLINICAL FINDINGS

A. Symptoms and Signs

1. Joint symptoms

The clinical manifestations of rheumatoid arthritis are highly variable, but joint symptoms usually predominate. Although acute presentations may occur, the onset of articular signs of inflammation is usually insidious, with prodromal symptoms of vague periarticular pain or stiffness. Symmetric swelling of multiple joints with tenderness and pain is characteristic. Monoarticular disease is occasionally seen initially. Stiffness persisting for longer than 30 minutes (and usually many hours) is prominent in the morning. Stiffness may recur after daytime inactivity and be much more severe after strenuous activity. Although any diarthrodial joint may be affected, PIP joints of the fingers, MCP joints (Figure 20–3), wrists, knees, ankles, and MTP joints are most often involved. Synovial cysts and rupture of tendons may occur. Entrapment syndromes are common—particularly of the median nerve at the carpal tunnel of the ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.